Claire Tebbutt

Charles River Laboratories (United Kingdom) — United Kingdom

Medicine · Health Sciences

3h-index49citations5works8.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(2), Virus-based gene therapy research(2), Viral gastroenteritis research and epidemiology(2), Monoclonal and Polyclonal Antibodies Research(2), Viral Infections and Immunology Research(2)

Publications5 total

Human cell surface-AAV interactomes identify LRP6 as blood-brain barrier transcytosis receptor and immune cytokine IL3 as AAV9 binder
Nature Communications·2024· 13 citedOpen Access
Human cell surface-AAV interactomes identify LRP6 as blood-brain-barrier transcytosis receptor and immune cytokine IL3 as AAV9 binder
2024· 3 citedOpen Access
Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses
Frontiers in Immunology·2021· 28 citedOpen Access
Deep mining of early antibody response in COVID-19 patients yields potent neutralisers and reveals high level of convergence
2020· 3 citedOpen Access
Abstract 3877: MPL-5821, a macrophage targeted ESMTM p38 MAPK inhibitor, inhibits the production of TLR agonist induced IL-10 whilst sparing T-cell functionality
Cancer Research·2018· 2 cited

Frequent Co-authors

Georgia Bullen(2), Jacob D. Galson(2), Gareth Hall(2), Primitivo Caballero(2), Lien Moreels(2), Line Ledsgaard(2), Giada Mattiuzzo(2), Emma Bentley(2), Edward W. Masters(2), David Tang(2), Sophie Millett(2), Danielle Tongue(2), R. H. Brown(2), Ioannis Diamantopoulos(2), Kothai Parthiban(2), Rachael A. Leah(2), Krishna Chaitanya(2), Deividas Pazeraitis(2), Sachin Surade(2), Omodele Ashiru(2)